THE DUBERSTEIN GROUP INC. for AMGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Research and experimentation tax incentives and international tax issues, including: Administration's FY 2014 corporate tax proposals. Tax reform, including House Ways and Means and Senate Finance discussion draft.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Medicare/Medicaid MMM
Sustainable growth rate - S 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014; S 2122, Responsible Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014; HR 2810, Medicare Patient Access and Quality Improvement Act of 2013; HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014; HR 4302, Protecting Access to Medicare Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.